Back

Fap-directed CAR macrophage therapy improves cardiac function and reduces fibrosis in Dsg2-mutant arrhythmogenic cardiomyopathy mice

30 August 2026 (16:35 - 16:45)
Organised by: Logo
Congress Presentation Part of: Molecular and genetic insights into cardiac arrhythmias Arrhythmogenic Right Ventricular Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Yiqi Zhao

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Buccal cells show reduced mitochondrial complex i expression in Brugada syndrome
Mr L. Mcguire (London, GB)
Abstract Slides
Presentation thumbnail
Non-invasive electrocardiographic imaging of torsades de pointes in an ovine model of drug-induced QT prolongation: recovery dispersion sets the stage, and abnormal impulse formation pulls the trigger
Doctor P. Deissler (Essen, DE)
Abstract Slides
Presentation thumbnail
Cardiomyocyte-derived Reg3γ drives aging-related atrial fibrillation by activating macrophages via the gp130/JAK1/STAT3 pathway
Doctor N. Zhang (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Prevalence and disease expression of pathogenic and likely pathogenic variants associated with ARVC in a large cohort
Mr Z. Zhang (Zurich, CH)
Abstract Slides
Presentation thumbnail
Non-invasive electrocardiographic imaging in arrhythmia-susceptible patients with the SCN5A founder mutation c.4850_4852delTCT reveals concealed regional activation and repolarization abnormalities
Doctor P. Deissler (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Molecular and genetic insights into cardiac arrhythmias
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 16:35 CET
You may be interested in
thumbnail
Congress Presentation
Activation of cardiac macrophages, endothelial cells and fibroblasts in experimental autoimmune myocarditis
29 August 2022
thumbnail
Congress Presentation
Right ventricular dysfunction in hematologic patients exposed to Chimeric Antigen Receptor (CAR)-T cells therapy: results from the prospective CARdio-TOX study.
21 June 2025
thumbnail
Congress Presentation
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy
25 April 2024
thumbnail
Congress Presentation
Pathogenic mechanism of DSG2-F531C mutation caused arrhythmogenic right ventricular cardiomyopathy
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources